BioVie (BIVI) Institutional Ownership $1.90 -0.18 (-8.65%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for BioVie (NASDAQ:BIVI)CurrentInstitutional OwnershipPercentage4.59%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$337.07KNumber ofInstitutional Sellers(last 12 months)0 Get BIVI Insider Trade Alerts Want to know when executives and insiders are buying or selling BioVie stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BIVI Institutional Buying and Selling by Quarter Ad Crypto 101 MediaThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW BioVie Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2024 Sheaff Brock Investment Advisors LLC51,400$27K0.0%+276.9%0.129% 5/7/2024CVI Holdings LLC599,897$317K0.3%N/A1.503% 11/7/2023 Jump Financial LLC10,000$34K0.0%N/A0.027% 10/30/2023 Summit Trail Advisors LLC10,100$34K0.0%N/A0.027% 10/25/2023 Crescent Grove Advisors LLC11,000$38K0.0%N/A0.030% 10/24/2023 Bank of New York Mellon Corp15,955$54K0.0%-51.2%0.043% Get the Latest News and Ratings for BIVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioVie and its competitors with MarketBeat's FREE daily newsletter. 8/29/2023 Garde Capital Inc.24,163$104K0.0%+40.8%0.066% 7/20/2023AJ Wealth Strategies LLC23,474$101K0.0%+52.2%0.065% 7/11/2023FNY Investment Advisers LLC8,986$38K0.0%N/A0.025% 5/4/2023 Barclays PLC54,117$437K0.0%+117.7%0.150% 4/28/2023AJ Wealth Strategies LLC15,428$125K0.0%N/A0.043% 2/24/2023 Garde Capital Inc.17,163$133K0.0%N/A0.049% 2/14/2023 683 Capital Management LLC16,110$125K0.0%N/A0.053% 2/14/2023swisspartners Ltd.294,346$2.29M2.9%+82.8%0.964% 2/7/2023Commonwealth Equity Services LLC12,175$94K0.0%N/A0.040% 2/1/2023 Bank of Montreal Can10,000$78K0.0%N/A0.033% 1/30/2023 International Assets Investment Management LLC10,500$82K0.0%N/A0.034% 1/10/2023FNY Investment Advisers LLC14,200$110K0.2%N/A0.047% 11/15/2022 Pura Vida Investments LLC36,617$91K0.0%N/A0.120% 5/4/2022swisspartners Ltd.10,367$1.87M1.3%-87.1%0.042% 2/14/2022 Long Focus Capital Management LLC20,000$90K0.0%N/A0.080% 11/16/2021swisspartners Ltd.80,521$542K0.4%+45.0%0.323% 11/12/2021 Renaissance Technologies LLC53,100$355K0.0%+90.3%0.214% 8/13/2021 Renaissance Technologies LLC27,900$473K0.0%N/A0.200% 8/13/2021 Geode Capital Management LLC22,898$388K0.0%+8.0%0.164% 8/13/2021 Vanguard Group Inc.97,804$1.66M0.0%+267.6%0.700% 8/11/2021swisspartners Ltd.55,521$941K0.7%+2.2%0.397% 5/18/2021 Millennium Management LLC23,107$447K0.0%-3.7%0.166% 5/17/2021 Ameriprise Financial Inc.90,876$1.76M0.0%N/A0.651% 5/12/2021 Geode Capital Management LLC21,200$410K0.0%N/A0.152% 5/12/2021swisspartners Ltd.54,300$1.05M0.9%-27.6%0.390% 5/7/2021 Sowell Financial Services LLC2,000$26K0.0%N/A0.014% 3/11/2021swisspartners Ltd.75,000$1.28M1.1%N/A0.539% 2/16/2021 HN Saltoro Capital LP15,000$260K0.1%N/A0.108% (Data available from 1/1/2016 forward) BIVI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BIVI shares? During the previous two years, 15 institutional investors and hedge funds held shares of BioVie. The most heavily invested institutionals were swisspartners Ltd. ($2.29M), Barclays PLC ($437K), CVI Holdings LLC ($317K), 683 Capital Management LLC ($125K), Garde Capital Inc. ($104K), AJ Wealth Strategies LLC ($101K), and Commonwealth Equity Services LLC ($94K).Learn more on BIVI's institutional investors. What percentage of BioVie stock is owned by institutional investors? 4.59% of BioVie stock is owned by institutional investors. Learn more on BIVI's institutional investor holdings. Which institutional investors have been buying BioVie stock? Of the 14 institutional investors that purchased BioVie stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: CVI Holdings LLC ($599.90K), swisspartners Ltd. ($133.35K), Sheaff Brock Investment Advisors LLC ($37.76K), Barclays PLC ($29.26K), Garde Capital Inc. ($24.16K), AJ Wealth Strategies LLC ($23.47K), and FNY Investment Advisers LLC ($23.19K). How much institutional buying is happening at BioVie? Institutional investors have bought a total of 950,977 shares in the last 24 months. This purchase volume represents approximately $2.57M in transactions. Which BioVie major shareholders have been selling company stock? The following institutional investors have sold BioVie stock in the last 24 months: Bank of New York Mellon Corp ($16.76K). How much institutional selling is happening at BioVie? Institutional investors have sold a total of 16,763 shares in the last 24 months. This volume of shares sold represents approximately $57.16K in transactions. Related Companies Bright Minds Biosciences Institutional Ownership Corbus Pharmaceuticals Institutional Ownership Innate Pharma Institutional Ownership Sagimet Biosciences Institutional Ownership Actuate Therapeutics Institutional Ownership Sutro Biopharma Institutional Ownership Caribou Biosciences Institutional Ownership 2seventy bio Institutional Ownership Nkarta Institutional Ownership Checkpoint Therapeutics Institutional Ownership This page (NASDAQ:BIVI) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
